cetirizine has been researched along with Infections, Respiratory in 4 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Anti-inflammatory properties in 36%, allergy in anamnesis in 14% and allergic symptoms in 28% were pointed out by polish doctors as the main reasons for prescriptions of cetirizine." | 5.33 | [Cetirizine and respiratory tract infections in opinion of Polish doctors]. ( Jahnz-Rózyk, K, 2006) |
| "The presented results indicate the effectiveness of theoritin and cetirizine in the treatment of patients with seasonal exacerbation of allergic rhinitis, comorbid for acute respiratory viral infections." | 4.12 | [Modern H1 antihistamines in the treatment of patients with allergic rhinitis and comorbid acute respiratory infections]. ( Miroshnichenko, NA; Nikolaeva, YO; Ovchinnikov, AY, 2022) |
| "Anti-inflammatory properties in 36%, allergy in anamnesis in 14% and allergic symptoms in 28% were pointed out by polish doctors as the main reasons for prescriptions of cetirizine." | 1.33 | [Cetirizine and respiratory tract infections in opinion of Polish doctors]. ( Jahnz-Rózyk, K, 2006) |
| "Cetirizine was absorbed more slowly in children (p = 0." | 1.29 | A pharmacokinetic evaluation of the second-generation H1-receptor antagonist cetirizine in very young children. ( Dab, I; Desager, JP; Harvengt, C; Horsmans, Y, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ovchinnikov, AY | 1 |
| Miroshnichenko, NA | 1 |
| Nikolaeva, YO | 1 |
| Hogan Ii, RB | 1 |
| Hogan Iii, RB | 1 |
| Cannon, T | 1 |
| Rappai, M | 1 |
| Studdard, J | 1 |
| Paul, D | 1 |
| Dooley, TP | 1 |
| Jahnz-Rózyk, K | 1 |
| Desager, JP | 1 |
| Dab, I | 1 |
| Horsmans, Y | 1 |
| Harvengt, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) to Evaluate the Safety and Efficacy of Drug Combinations in COVID-19 Patients[NCT05077332] | Phase 2 | 2,000 participants (Anticipated) | Interventional | 2021-12-29 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 other studies available for cetirizine and Infections, Respiratory
| Article | Year |
|---|---|
[Modern H1 antihistamines in the treatment of patients with allergic rhinitis and comorbid acute respiratory infections].
Topics: Adult; Cetirizine; Female; Histamine Antagonists; Histamine H1 Antagonists; Humans; Inflammation; Ma | 2022 |
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Betacoronavirus; Cetirizine; Cohort Studies; Coronavirus | 2020 |
[Cetirizine and respiratory tract infections in opinion of Polish doctors].
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Cetirizine; Child; Child, Preschool; Comorbidity; Dru | 2006 |
A pharmacokinetic evaluation of the second-generation H1-receptor antagonist cetirizine in very young children.
Topics: Absorption; Adult; Cetirizine; Child, Preschool; Female; Half-Life; Humans; Hypersensitivity; Male; | 1993 |